Search

Your search keyword '"Funck-Brentano C"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Funck-Brentano C" Remove constraint Author: "Funck-Brentano C" Topic anti-arrhythmia agents Remove constraint Topic: anti-arrhythmia agents
22 results on '"Funck-Brentano C"'

Search Results

1. Effectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodarone.

2. Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias.

3. Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity.

4. Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics.

5. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.

6. Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: comparison with the standard form and influence of the CYP2D6 polymorphism.

7. [Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study].

8. Dynamic analysis of dofetilide-induced changes in ventricular repolarization.

9. Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers.

10. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization.

11. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.

12. Rate-dependence of class III actions in the heart.

13. [Potassium channels and arrhythmia].

14. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].

15. Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers.

16. Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drug.

17. [Pertinence of animal and human models in the evaluation of ventricular anti-arrhythmia agents].

18. Overview of the clinical pharmacology of antiarrhythmic drugs.

19. Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias.

21. Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

22. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Catalog

Books, media, physical & digital resources